Brief: Aurobindo Pharma To Buy Non-Oncology Prescription Formulations Business Of Khandelwal Laboratories
01/01/2026 13:29
Jan 1 (Reuters) - Aurobindo Pharma Ltd ARBN.NS: TO BUY NON-ONCOLOGY PRESCRIPTION FORMULATIONS BUSINESS OF KHANDELWAL LABORATORIES CASH CONSIDERATION OF 3.25 BILLION RUPEES FOR ACQUISITION Further company coverage: ARBN.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11